Early treatment key to combating hepatitis C virusAugust 9th, 2008 - 2:52 pm ICT by IANS
Toronto, Aug 9 (IANS) Patients who receive timely treatment for the Hepatitis C virus after infection develop a comprehensive immune response against the virus, according to a new study published in the Journal of Virology. Therefore, early treatment can restore immune response against Hapatitis C virus and help to eliminate it rapidly. This new discovery of the mechanisms of viral eradication could spur development of new treatments.
About a quarter of infected individuals are known to eradicate the infection spontaneously, sans treatment, according to the study.
Led by Naglaa Shoukry and Julie Bruneau, affiliated to both the Université de Montréal Hospital Centre and the Université de Montréal, as well as with other researchers, the study found that early treatment restores a rapid poly-functional immune response, characterized by simultaneous production of multiple antiviral mediators.
HCV is transmitted through infected blood. Although a quarter of infected patients can eradicate the infection spontaneously, the majority develop persistent infection, a major cause of cirrhosis and cancer of the liver.
The only approved treatment for HCV is an anti-viral drug known as pegylated interferon alpha. This drug is successful in only half of cases when administered during chronic infection. Success rates among those treated early after infection are significantly higher or around 90 percent.
In North America alone, most new HCV infections occur among intravenous drug users (IDUs), a vulnerable population that is often undiagnosed and untreated. In the study, researchers followed a group of IDUs at high risk of HCV infection before and immediately after exposure to HCV.
Their findings clearly show the importance of early diagnosis and treatment of HCV - particularly in marginalised populations such as IDUs and aboriginal populations.
- Early treatment key to fight hepatitis C virus - Aug 09, 2008
- New find may offer protection against hepatitis C treatment-related anemia - Jan 26, 2011
- Not portraying drug users as dead can improve HIV treatment access - Jul 22, 2010
- First vaccine for viral hepatitis C may soon become a reality - Apr 02, 2011
- Scientists identify molecule that flicks on immune system - May 21, 2012
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- Hepatitis C virus infection linked to fat enzyme in liver cells - Oct 11, 2010
- New strategy could increase antiviral drugs' effectiveness - Jul 20, 2010
- New therapy could help beat Hepatitis C virus - Jan 17, 2012
- Early warning alerts our cells against invading bugs - Oct 16, 2011
- Hepatitis C vaccine undergoing trials - Aug 16, 2012
- Coffee can cure hepatitis C - Jun 08, 2011
- Is cure for common cold in sight? - Nov 02, 2010
- Shark liver compound could treat dengue, hepatitis - Sep 20, 2011
- Hepatitis C: Cure and control, right now! - Jul 29, 2010
Tags: aboriginal populations, cancer of the liver, chronic infection, cirrhosis, hapatitis c, hcv infections, hepatitis c, hepatitis c virus, immune response, interferon alpha, intravenous drug users, journal of virology, naglaa, new discovery, pegylated interferon, persistent infection, simultaneous production, study researchers, timely treatment, vulnerable population